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Abstract: Fasting and postprandial triglyceride concentrations largely depend on dietary 
and lifestyle factors. Alcohol intake is associated with triglycerides, but the effect of 
alcohol on diurnal triglyceridemia in a free living situation is unknown. During three days, 
139 men (range: 18–80 years) measured their own capillary triglyceride (cTG) 
concentrations daily on six fixed time-points before and after meals, and the total daily 
alcohol intake was recorded. The impact of daily alcohol intake (none; low, <10 g/day; 
moderate, 10–30 g/day; high, >30 g/day) on diurnal triglyceridemia was analyzed by the 
incremental area under the cTG curve (∆cTG-AUC) reflecting the mean of the six different 
time-points. Fasting cTG were similar between the alcohol groups, but a trend of increased 
cTG was observed in men with moderate and high alcohol intake after dinner and at 
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bedtime (p for trend <0.001) which persisted after adjustment for age, smoking and body 
mass index. The ∆cTG-AUC was significantly lower in males with low alcohol intake  
(3.0 ± 1.9 mmol·h/L) (n = 27) compared to males with no (7.0 ± 1.8 mmol·h/L) (n = 34), 
moderate (6.5 ± 1.8 mmol·h/L) (n = 54) or high alcohol intake (7.2 ± 2.2 mmol·h/L)  
(n = 24), when adjusted for age, smoking and body mass index (adjusted p value < 0.05). 
In males, low alcohol intake was associated with decreased diurnal triglyceridemia, 
whereas moderate and high alcohol intake was associated with increased triglycerides after 
dinner and at bed time. 
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1. Introduction 
Many factors determine fasting and postprandial plasma triglycerides (TG) [1] like gender, age, 
physical activity, body mass index, dietary habits and genetic factors [2–5]. There is substantial 
evidence that high alcohol intake has been associated with an increase in TG and subsequent increased 
risk for the development of pancreatitis [6]. However, the association between alcohol and TG is 
complex and does not always fit a simple linear association since a J-shaped association between 
alcohol intake and TG has recently been described [7,8]. This reported J-shaped association is similar 
to the J-shaped association between alcohol intake and cardiovascular risk [9–13]. These epidemiologic 
studies suggest that low amounts of alcohol intake may lower TG concentrations. However, evidence 
concerning the effect of low to moderate alcohol intake in relation to TG is inconsistent. Decreased, 
unchanged and increased TG have all been described in relation to small-to moderate alcohol  
intake [12,14–18], whereas high alcohol intake has been consistently related to elevated TG [15,19]. 
Differences may exist between the effects of alcohol on fasting and postprandial TG since a 
postprandial increase in alcohol-mediated free fatty acid oxidation may exaggerate postprandial 
triglyceridemia while fasting TG remained within normal ranges [20]. 
The effect of alcohol consumption on diurnal triglyceridemia has not yet been studied and data on 
the impact of alcohol on both fasting and non-fasting TG in an uncontrolled real life situation are 
limited. In this observational study we investigated the impact of alcohol consumption on capillary TG 
concentrations (cTG) during the day determined in free living male subjects, using a hand-held  
point-of-care testing device [2,21–25]. 
2. Experimental Section 
2.1. Subjects 
Subjects were healthy male volunteers or patients, aged from 18 to 80 years, with hyperlipidemia,  
a known medical history of cardiovascular disease (CVD) or type 2 diabetes mellitus (T2DM) 
participating in several clinical studies with the same protocol, aimed at investigating factors 
influencing postprandial lipemia [2,21–25]. Exclusion criteria were the presence of renal, liver or 
thyroid disease. Subjects using lipid lowering drugs were investigated after withdrawal of these drugs 
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during four weeks. Height, weight, body mass index (BMI) and blood pressure were measured at 
inclusion. The study was approved by the Local Medical Ethical Committee of the UMC Utrecht 
(University Medical Center Utrecht, Utrecht, The Netherlands). The study protocol has been registered 
at Clinicaltrials.gov (NCT01786421). 
2.2. Analytical Determinations 
Fasting blood samples were collected at inclusion after a period of 12 h fasting for measurement of 
lipids, apolipoproteins, insulin and glucose from plasma. Cholesterol, plasma triglycerides (TG) and 
high density lipoprotein (HDL) cholesterol (obtained after precipitation with dextransulphate/MgCl2), 
were determined using a Vitros 250 analyzer (Johnson & Johnson, Rochester, NY, USA). Plasma 
apolipoprotein (apo) B was measured by nephelometry using apo B monoclonal antibodies (Behring 
Diagnostics NV, OSAN 14/15, Marburg, Germany). Plasma apo AI was measured by nephelometry 
using apo AI monoclonal antibodies (Behring Diagnostics NV, OUED 14/15). Plasma glucose was 
measured by glucose oxidase dry chemistry (Vitros GLU slides, Johnson & Johnson, Clinical Diagnostics, 
Rochester, NY, USA) and colorimetry, and insulin was measured by competitive radio immunoassay 
with polyclonal antibodies. Low density lipoprotein (LDL) cholesterol was calculated using the 
Friedewald formula. 
2.3. TG Self-Measurements 
Self-measurements of cTG were performed with a hand-held point-of-care testing device 
(Accutrend GCT®, Roche Diagnostics, Mannheim, Germany). Subjects were instructed to carefully 
wash and dry their hands thoroughly before each measurement. With a lancing device, a drop of blood 
(30 μL) from the finger was obtained, which was applied to the TG test strip in the TG analyzer. The 
subjects recorded the diurnal TG profile in a diary. They were instructed to measure their cTG for 
three days (preferably on Monday, Wednesday and Friday) on the following fixed time-points: fasting, 
before lunch, 3 h after lunch, before dinner, 3 h after dinner and at bedtime. Subjects were requested to 
avoid heavy physical activity, although normal daily activities were allowed. The measurement range 
for cTG was 0.80–6.86 mmol/L. The TG-analyser is known to measure TG reliably, regardless of the 
nature of the TG-carrying lipoprotein species. The correlation coefficient between cTG measurements 
with the TG-analyser and plasma measurements according to enzymatic methods is 0.94 [26].  
Similar results have been obtained in our laboratory [2,21]. Capillary TG concentrations are generally 
0.2–0.3 mmol/L higher than TG concentrations in venous plasma [25], which may reflect differences 
between capillary and venous samples or differences in methodology. 
2.4. Dietary Intake 
Dietary intake on the days of cTG measurements was recorded in a diary. All answered 
questionnaires were evaluated individually by a trained physician together with each subject. 
Quantities of daily intake were estimated according to guidelines given by a dietician. Foods consumed 
were converted into nutrients with a version of the Dutch Nutrient Data Base [27]. Alcohol 
consumption of less than 10 g/day was considered low, 10–30 g/day was considered moderate and 
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more than 30 g/day was considered high, as described previously [28]. The exact time of alcohol 
consumption during the day was not recorded. Subjects did not receive any suggestion concerning  
the composition and frequency of their meals and were requested to use their regular diet and alcohol 
drinking pattern during the study. 
2.5. Statistics 
Data were obtained from different studies using the same protocol. Data are given as mean ± SD 
unless stated otherwise. Alcohol intake was divided into: none, low (<10 g/day), moderate  
(10–30 g/day) and high (>30 g/day). Differences between groups were tested by ANOVA with 
Bonferroni as post hoc analysis test, Chi-square test or Fisher’s exact test where appropriate. 
ANCOVA was used to test for significant differences in cTG between alcohol groups at the  
six independent time-points adjusted for age, body mass index (BMI) and smoking. Diurnal 
triglyceridemia was defined as the incremental area under the curve (∆cTG-AUC). Dietary intake and 
diurnal triglyceridemia were calculated using the average over two or three days. Linear regression 
analysis was used to test for significant differences in diurnal triglyceridemia between the different 
alcohol groups with and without adjustment for age, BMI and smoking, since BMI closely correlates 
with TG and alcohol intake interacts with both smoking and TG [29]. Logarithmic transformation was 
performed for plasma and capillary TG in order to obtain a normal distribution, but untransformed 
values are shown in the text and tables. All statistical analyses were performed using PASW statistics 
version 18.0 (SPSS Inc., Chicago, IL, USA). The ∆cTG-AUC was calculated with PRISM version 3.0 
(Graph Pad Software, San Diego, CA, USA). Statistical significance was set at p < 0.05 (two-sided). 
3. Results 
General characteristics of the 139 male subjects are shown in Table 1. The clinical characteristics 
according to alcohol intake are shown in Table 2. Men with high alcohol intake were significantly 
older compared to men who did not consume alcohol. Men with high alcohol consumption were more 
frequently smokers compared to men with less alcohol intake. The BMI tended to be lower in men 
with low alcohol intake (p for trend 0.07). No differences were found in fasting plasma TG between 
males with different amounts of alcohol consumption. Total energy intake was similar between alcohol 
groups (Table 2). 
Patterns for diurnal capillary triglyceridemia according to alcohol intake are shown in Figure 1.  
No significant differences were found in fasting cTG and ∆cTG-AUC within the different groups 
between the three individual measurement days. A pronounced diurnal cTG increase ranging from  
0.40 ± 1.00 to 1.20 ± 0.99 mmol/L was observed in all four groups. No differences in cTG between the 
alcohol groups were observed at time-points fasting until before dinner neither in the univariate 
analysis nor, after adjustment for age, BMI and smoking. However, the cTG differed significantly 
between the alcohol groups after dinner (p for trend <0.001) and at bedtime (p for trend <0.001),  
which persisted after adjustment for age, BMI and smoking (p = 0.036 and p = 0.006, respectively) 
(Figure 1). Low alcohol intake was associated with decreased cTG, whereas moderate and high alcohol 
intake was associated with increased cTG after dinner and at bedtime. 
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No significant differences were found for the ∆cTG-AUC between no, low, moderate and high 
alcohol intake in the univariate analysis (Table 2). However, after adjustment for age, smoking and 
BMI, men with low alcohol intake had a significantly lower ∆cTG-AUC compared to men with no, 
moderate or high alcohol intake (adjusted p < 0.05) (Table 2). 
Table 1. Clinical and biochemical characteristics of the 139 participants to the study. 
Characteristic (n = 139) 
Age (years) 39.9 ± 14.2
BMI (kg/m2) 24.6 ± 3.4 
SBP (mmHg) 125.0 ± 13.5
DBP (mmHg) 81.5 ± 10.2
Smoking (n, %) 35 (25.2%)
History of CAD (n, %) 27 (19.4%)
History of T2DM (n, %) 3 (2.2%) 
Total cholesterol (mmol/L) 5.30 ± 1.04
LDL-C (mmol/L) 3.45 ± 1.00
HDL-C (mmol/L) 1.23 ± 0.31
Apolipoprotein B (g/L) 0.97 ± 0.24
Apolipoprotein A–I (g/L) 1.32 ± 0.22
Plasma triglycerides (mmol/L) 1.35 ± 0.77
Alcohol Intake 
None (n, %) 34 (24.5%)
Low, <10 g/day (n, %) 27 (19.4%)
Moderate, 20–30 g/day (n, %) 54 (38.8%)
High, >30 g/day (n, %) 24 (17.3%)
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; CAD = coronary 
artery disease; T2DM = type 2 diabetes mellitus; LDL-C = low density lipoprotein cholesterol;  
HDL-C = high density lipoprotein cholesterol. 
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Table 2. Clinical, biochemical characteristics and dietary intake for male subjects depending on alcohol intake. Data are given as mean ± SD 
unless stated otherwise. * Adjusted for age, smoking habits and BMI; a Significantly different from corresponding value in no alcohol intake 
(p < 0.05); b Significantly different from corresponding values of all other groups (p < 0.05); c Significantly different from corresponding 
values of all other groups (adjusted p < 0.05). 
Characteristics 
Alcohol Intake 
No Low Moderate High 
(n = 34) (n = 27) (n = 54) (n = 24) 
Alcohol intake (g/day) 0.0 ± 0.0 5.4 ± 2.7 19.9 ± 6.2 61.5 ± 43.0 
Age (years) 34.9 ± 14.5 41.7 ± 13.4 39.9 ± 15.0 45.2 ± 10.9 a
BMI (kg/m2) 24.6 ± 3.4 23.8 ± 2.9 24.6 ± 3.6 25.4 ± 3.8 
SBP (mmHg) 127.4 ± 14.2 122.1 ± 11.1 124.4 ± 13.5 126.4 ± 15.1 
DBP (mmHg) 83.0 ± 8.9 81.9 ± 9.2 80.5 ± 10.2 81.1 ± 12.6 
Smoking (n, %) 6 (17.6%) 5 (18.5%) 12 (22.2%) 12 (50.0%) b
History of CAD (n, %) 6 (17.6%) 3 (11.1%) 10 (18.5%) 8 (33.3%) 
History of T2DM (n, %) 2 (5.9%) 1 (3.7%) 2 (3.7%) 1 (4.2%) 
Total cholesterol (mmol/L) 5.08 ± 1.13 5.17 ± 1.11 5.33 ± 1.04 5.34 ± 0.83 
LDL-C (mmol/L) 3.27 ± 1.01 3.35 ± 1.09 3.47 ± 0.98 3.43 ± 0.84 
HDL-C (mmol/L) 1.20 ± 0.29 1.20 ± 0.37 1.24 ± 0.32 1.27 ± 0.27 
Apolipoprotein B (g/L) 0.89 ± 0.22 0.99 ± 0.29 0.99 ± 0.22 1.02 ± 0.26 
Apolipoprotein A–I (g/L) 1.34 ± 0.24 1.34 ± 0.23 1.27 ± 0.19 1.38 ± 0.22 
Plasma triglycerides (mmol/L) 1.32 ± 0.78 1.32 ± 0.75 1.38 ± 0.66 1.38 ± 1.04 
Fasting plasma glucose (mmol/L) 5.17 ± 0.60 5.29 ± 093 5.43 ± 1.95 5.32 ± 0.69 
Fasting plasma insulin (UI/L) 8.47 ± 3.89 9.20 ± 6.07 8.25 ± 418 10.65 ± 11.59
Dietary carbohydrates intake (g/day) 278.48 ± 81.68 282.26 ± 58.33 273.60 ± 78.79 265.15 ± 68.05
Dietary fat intake (g/day) 86.95 ± 28.37 93.00 ± 24.93 87.48 ± 26.67 89.98 ± 20.95
Dietary MUFA intake (g/day) 32.96 ± 13.22 36.80 ± 10.77 33.90 ± 11.39 35.07 ± 8.93 
Dietary PUFA intake (g/day) 13.61 ± 5.66 15.72 ± 4.67 13.68 ± 5.21 15.47 ± 4.48 
Dietary saturated fat intake (g/day) 32.59 ± 10.72 34.02 ± 9.13 32.48 ± 10.36 32.66 ± 8.02 
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Table 2. Cont. 
Energyintake (kcal/day) 2301.30 ± 586.35 2402.38 ± 481.40 2405.81 ± 608.94 2651.58 ± 599.32
∆cTG-AUC (mmol·h/L) 6.8 ± 7.0 2.8 ± 7.3 6.5 ± 5.6 7.4 ± 6.3 
∆cTG-AUC (mmol·h/L) adjusted * 7.1 ± 1.8 3.1 ± 1.9 c 6.5 ± 1.8 7.3 ± 2.2 
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; CAD = coronary artery disease; T2DM = type 2 diabetes mellitus;  
LDL-C = low density lipoprotein cholesterol; HDL-C = high density lipoprotein cholesterol; MUFA = Mono-unsaturated fatty acids; PUFA = Poly-unsaturated fatty acids; 
∆cTG-AUC = incremental area under the curve for daytime capillary triglycerides. 
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Figure 1. Diurnal capillary triglyceride patterns according to alcohol intake. Data are 
shown as mean ± SEM. ** Significant differences in cTG for a specific time-point  
(p for trend <0.001). 
 
4. Discussion 
Our study suggests that low alcohol intake is associated with a decrease in diurnal triglyceridemia 
in males after adjustment for age, BMI and smoking. Our results are in line with a recent meta-analysis 
and other studies on alcohol consumption, suggesting that small to moderate alcohol consumption is 
associated with slightly lowered plasma TG [7,8]. A recent study described that three to twenty 
alcoholic drinks per week were associated with lower plasma TG compared to subjects who did not 
drink or those who consumed >20 alcoholic drinks per week [8]. A similar trend was observed in the 
Danish general population who participated in the Copenhagen City Heart Study [30]. The probability 
value for a U-shape was significant in women (p = 0.006), but not in men (p = 0.23), although men 
showed a similar trend [9]. The association between low alcohol intake and a decrease in diurnal 
triglyceridemia may be due to genetic interactions with alcohol intake or the type of alcoholic 
beverages consumed, but this needs further investigation [6]. 
We also observed a trend that moderate and high alcohol intake was associated with increased 
postprandial TG after dinner and at bedtime. The lack of differences before dinner most likely reflects 
an efficient TG clearance mechanism in this relatively healthy population. Moreover, since alcohol 
consumption occurred mostly around dinner as is usually the case in a healthy population [24],  
the most significant effects of alcohol consumption were found after dinner. However, an animal study 
showed that chronic alcohol consumption increases postprandial TG without affecting fasting TG, 
which may suggest that the time of alcohol consumption per se is less important than the amount of 
alcohol consumed [31]. In contrast, it was recently shown in an experimental study that 0.6 g alcohol 
per kg body weight significantly increased postprandial TG with a prolonged postprandial lipemic 
response when the alcohol was consumed at breakfast [32]. Increased fasting TG without prolongation 
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of the postprandial TG response was observed when a similar dose of alcohol was consumed the 
evening before (12 h before breakfast). These results suggest that alcohol consumption in the evening 
affects fasting TG as well. 
Clear mechanistic metabolic explanations are present to explain the increase in TG upon high 
alcohol intake. Alcohol has been shown to stimulate the secretion of very low density lipoproteins,  
to reduce lipoprotein lipase activity, to stimulate adipose tissue lipolysis resulting in elevated hepatic 
delivery of free fatty acids and to impair the oxidation of fatty acids in the mitochondria [20,32–34].  
In addition, the literature is consistent regarding high alcohol intake and increased TG [12,35].  
For example, increased postprandial TG was observed after dinner when 40 g of alcohol was 
consumed daily for a period of three weeks [36]. These results are comparable with our observations, 
because a trend for increased cTG in males with moderate and high alcohol intake was observed after 
dinner and at bedtime. 
Theoretically, it is possible that a bias was introduced and that some of the subjects altered their 
drinking habits during the study despite the fact that we asked all participants to adhere to their regular 
diet and drinking habits. Another limitation of the present study is the possibility of inaccuracy in the 
self-reported amount of alcohol intake, due to the fact that we used questionnaires and diaries [37]. 
However, all answered questionnaires were evaluated individually, which may have improved the 
validity. It should be noted that we did not observe significant differences in HDL-C among the 
alcohol groups although it is known that chronic alcohol consumption increases HDL-C. In the present 
study we have evaluated the acute effects of alcohol consumption and we do not have data on chronic 
use. Subjects were in a free living, non-controlled situation with different drinking habits and meals, 
which could have affected lipoprotein metabolism [38,39]. The majority of subjects consumed wine 
and beer and therefore our results cannot be extrapolated to other beverages. The impact of different 
beverages on TG metabolism remains uncertain, but there is some evidence that red wine has a more 
favourable effect on TG when compared to other types of alcoholic drinks [7,40]. Low to moderate 
alcohol intake has been associated with healthier lifestyle habits, as well as with the consumption of 
specifically red wine [41]. Red wine contains polyphenols including resveratrol, which has TG 
lowering effects [42]. This may explain the lower diurnal triglyceridemia associated with low alcohol 
intake. Moreover, it was not possible to analyse the effect of different drinking patterns on diurnal 
triglyceridemia with our observational study design. 
5. Conclusions 
In males, low alcohol intake was associated with lower diurnal triglyceridemia when compared to 
no, moderate or high alcohol intake, which was most pronounced during the evening. High alcohol 
intake seems to contribute to increased TG during the evening. 
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